Nabriva Therapeutics Plc Net Income per Employee (NBRV), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Nabriva Therapeutics Plc  (NASDAQ: NBRV)
 

Nabriva Therapeutics Plc Net Income per Employee

NBRV's Quarterly Results, Trends, Rankings, Statistics
Nabriva Therapeutics Plc recorded a cumulative net loss of $-55 million during 12 month ending in the second quarter 2023.
The Healthcare sector has seen employees of 353 other companies achieving higher income per employee. While income per employee total ranking has improved so far to 4448, from total ranking in previous quarter at 4496.


What is Income per Employee Ratio?






NBRV Net Income per Employee (Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -1,376,350 -1,351,650 -1,429,625 -1,186,750 -1,165,200
NBRV's Total Ranking # 4448 # 4496 # 5107 # 4402 # 4468
Seq. Net Income Change - - - - -


NBRV Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 354
Healthcare Sector # 819
Overall Market # 4448

Net Income per Employee Statistics
High Average Low
$ -1,165,200 $ -1,795,662 $ -3,139,350
(Jun 30 2022)   (Jun 30 2019)







Companies with similar Income per Employee for 12 month ending Jun 30 2023, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2023Number of Employees Jun 30 2023


Date modified: 2026-09-08T15:11:04+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.